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Summary The a6/,B4 integrin complex has been shown to be expressed in murine tissues at the basolateral
aspect of most epithelial cells including the mammary epithelium, thus suggesting that this heterodimer may
interact with components of the basement membrane. Because transformation of mammary epithelium
frequently results in disappearance of basement membranes and loss of cell polarisation we have analysed in
the present study whether expression of the a6/P4 complex is altered in human breast tumours. The results of
the present study confirm that in human mammary gland a6 and P4 subunits colocalise at the basolateral
aspect of the epithelium. While in benign breast lesions this distribution pattern remains mostly unchanged, in
primary carcinomas the expression of both chains is either redistributed over the cell surface or significantly
reduced. This altered pattern of expression is paralleled by the lack of detection of basement membrane
laminin and collagen type IV. In metastatic lesions the expression of the heterodimer is maintained in most of
the lymphonodal foci, but less frequently detected in metastasis localised in the pleural cavity and in
parenchymal tissues. These findings indicate that in breast epithelium expression of the x6/P4 heterodimer is
modulated by the presence of basement membrane and is possibly influenced by microenvironmental factors as
suggested by the different pattern of x6/P4 expression in nodal and extranodal metastatic foci.
Integrins represent an expanding family of heterodimeric
receptors (Hynes, 1987) involved in cell-to-cell and cell
matrix interactions (Albelda & Buck, 1990). Accumulating
experimental evidence points to a major functional role of
integrins in the regulation of cell polarity (Fath et al., 1989)
and migration (Hemler, 1990) as well as in morphogenesis
(Korhonen et al., 1990). It has also been proposed that
derangement of integrin expression may be responsible for a
number of aberrant cell behaviours during tumour onset,
progression and metastatic spreading (Plantefaber & Hynes,
1989; Ruoslahti & Giancotti, 1989; Dedhar & Saulnier, 1990;
Giancotti & Ruoslahti, 1990).
In this context the VLA6 (Sonnenberg et al., 1987) integrin
which is formed by the non covalent association ofa6 and P1
chains is of particular interest since it represents a non
promiscuous receptor for the basement membrane glyco-
protein laminin (Sonnenberg et al., 1988). However, the a6
chain can alternatively associate with a different chain to
form the a6/,B4 heterodimer (Sonnenberg et al., 1988a;
Hemler et al., 1989; Kajiji et al., 1989) whose receptorial
activity is not yet fully characterised.
Detailed immunohistochemical studies of murine tissues
(Sonnenberg et al., 1990) have revealed that a6, P4 and P1
codistribute in most epithelia including the mammary
epithelium at the basolateral aspect, thus suggesting that
o6/P4 dimers physically interact with some basement mem-
brane component/s which may in turn modulate this expres-
sion and cellular compartimentalisation (Fath et al., 1989).
The observation that transformation of mammary epithelium
is frequently associated with lack of basement membranes
(Ozzello, 1979; Natali et al., 1984; Birembaut et al., 1985;
Tsubura et al., 1988) provides the opportunity to test this
hypothesis through the comparative analysis ofo6/P4 expres-
sion in normal and transformed primary and metastatic
human mammary epithelium.
We report here that in human breast tumours the lack of
laminin and collagen type IV i.e. basement membranes is
associated with a significantly reduced expression of oc6/P4 as
well as loss of its polarised pattern of expression.
Materials and methods
Tissues
Surgical biopsies of normal, benign and malignant tumour
tissues were collected following ablative surgery from patients
free of chemo and radiotherapy. Tissues were snap frozen in
liquid nitrogen. From each specimens consecutive 4 cryo-
stat sections were obtained which were fixed in cold absolute
acetone for 10min. Fixed sections were either immediately
used in immunohistochemical assay or kept frozen at - 3OC
with no loss of serological activity. Fixed sections stained
with 1% toluidine blue were used to evaluate the histological
features of the tissues.
Monoclonal andpolyclonal antisera
The murine monoclonal antibody (MoAb) A-1A5 to the P1
subunit (Hemler et al., 1983) was kindly provided by Dr
M.E. Hemler (Dana Farber Cancer Inst., Boston Ma., USA).
The rat MoAb 135-13C to the a6 (Falcioni et al., 1986) and
MoAb 439-9B (Falcioni et al., 1988) to the P4 integrin
subunits were kindly supplied by Dr A. Sacchi (Laboratory
of Molecular Oncogenesis, Regina Elena Cancer Inst., Rome,
Italy). Commercially available murine MoAb to a6 (HP2/1)
and 134 (3EI) were from Immunotech (Marseille, France) and
Telios Pharmaceutical Inc. (San Diego, Ca. USA) respec-
tively. Rabbit anti-laminin antiserum was purchased from
Chemicon Int. (El Segundo, Ca., USA). Murine monoclonal
antibodies to collagen type IV were purchased from Sigma
Chemical (St Louis. Mo. USA).
Immunohistochemical assay
Indirect immunoperoxidase (IIP) staining was performed by
employing on consecutive sections of the same specimen
primary MoAbs (25 to 50 fig ml-') and a commercially
available avidin-biotin staining kits (Vector Lab., Burlin-
game, Ca., USA). Because the affinity of MoAbs was un-
known the incubation with tissue sections was prolonged for
18 h. Negative controls consisted of tissue sections incubated
with irrelevant MoAb. The positive stain of the vascular
walls observable with antibodies provided a positive control
in each specimen studied. The immunoenzymatic reaction
employed 3-amino-9-ethylcarbazole as a chromogenic sub-
strate and Mayer's hematoxylin as nuclear counterstain
followed by mounting in buffered glycerol. Indirect
immunofluorescence was done as described (Natali et al.,
1981) using MoAb at the concentration of 25 fig ml'.
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Results
Expression ofc6 and134 subunits in normal mammary
epithelium and benign breast lesions
Immunohistochemical analysis of normal breast tissue
revealed a consistently strong stain for a6 and P4 which
outlined the outer aspect of acini and ducts independently
from the discontinuous (acini) and continuous (ducts) dis-
ribution of myoepithelial cells. A heterogenous stain of the
lateral aspect of luminal cells was seen with MoAb 135.13C
to x6 and was, even more pronounced with antibodies to P4
chain. Staining of a6 and P4 at the basal aspect of luminal
cells was rarely seen. By indirect immunofluorescence which
in our hands allowed a higher resolution, an ordered punc-
tuate stain could be observed for a6 and P4 in section planes
running tangential to the basal portion of the ductal and
acinar epithelium (Figure la inset). The extent to which
myoepithelial and luminal cells contributed to this pattern
could not be firmly established. The staining patterns des-
cribed above were maintained in three types of benign breast
tumours tested (Table I). Only in two cases of gynecomastia
was the plasma-membrane stain for a6 not associated with
detectable levels of P4.
Changes in distribution ofa6 andP4 subunits in primary and
metastatic breast tumours
Evaluation of primary breast tumours of the most common
histotypes (Table I) indicates that the expression of x6 and P4
subunits undergoes a number of changes. As a general rule,
P4 was never expressed in absence of x6. Three major stain-
ing patterns were observed. Staining for az6 and P4 in a
significant number of tumours was undetectable at the level
of the cell membrane (Figure lb). This was more frequently
seen in lobular and infiltrating ductal carcinomas while it was
less common in tubular tumours. Moreover polarised stain
for both subunits at the periphery of tumour cell nests
(Figure 1c) was rare in most tumour histotypes. The punc-
tuate stain at the base of tumour cell nests was never
observed.
The results of the comparative immunohistochemical
evaluation of primary tumours and autologous metastasis as
well as of metastasis from various anatomical sites are sum-
marised in Table II. Also in this instance three major staining
patterns could be observed since staining for P4 was never
observed in the absence of detectable a6 chain. Among
metastatic lesions, especially those located in lymph nodes
(40%) displayed stain for both subunits on tumour cell mem-
brane (Figure ld). In only four out of 26 metastases was a
polarisation of the stain for both chains seen at the periphery
of tumour cell nests. While the distribution of both subunits
in primary lesions was often (67%) different from that
observed in metastatic foci, the distribution of both chains
was rather consistent among multiple concomitant auto-
logous metastases. In one case (patient Br) whilst the primary
tumour lacked a6 and P4 stain, both chains were expressed in
the lymphonodal autologous lesions. As opposed to nodal
lesions, parenchymal and particularly pleural metastasis (ten
a
c 'i
Figure 1 Immunohistochemical distribution of x6/P4 integrin subunits in normal and transformed mammary epithelium. MoAb
135-13C to the a6 subunit decorates the basolateral aspect of normal ductal cells a. The stain appears more intense at the basal
region where by indirect immunofluorescence a fine row of punctate reaction may be seen (inset). b, Shows both normal (large
arrows) and transformed (small arrows) epithelium (IDC). The P4 subunit is present in the myoepithelial layer (large arrow) of
normal ducts and is variably expressed at the periphery of tumour cell nests (small arrows). a6 expression is maintained with a
normal pattern of distribution in a case of IDC c, Cells of a lymphonodal metastasis d, are heterogeneously reactive with MoAb
135-13C to the a6 chain. Indirect avidin-biotin immunoperoxidase. Counterstain Mayer's haematoxylin. (a-c, bar = 30 L; d,
bar = 20 i).320 P.G. NATALI et al.
Table I Pattern of expression ofa6 and P4 integrin subunits in benign and
malignant mammary lesions
Expression patterns
a6(+)P4(+) a6(+) P4(-) ex6(-)P4(-)
Malignant cell basal cell basal cell basal
IDC (27)a gb 3 6 4 12 20
LC (14) 3 4 2 3 9 7
TC (8) 5 2 2 2 1 4
Benign
Fibrocystic (6) 6 6
Fibroadenoma (7) 7 7
Gynecomastia (5) 3 5 2
b~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ aNumber of cases tested. bNumber of cases with a given staining pattern.
IDC: infiltrating ductal carcinoma. LC: lobular carcinoma. TC: tubular
carcinoma. Cell: expression on the cell surface. Basal: polarised expression at
the basal cell aspect of cell placed at the periphery of tumour cell nests.
Table II Pattern ofexpression ofa6/P4 intregrin in metastatic breast cancer
Expression patterns
Case Lesion Histotype ac6( + )p4( +) a6( + )p4(-) c6(-)1p4(-)
DC P IDC +
Ml (Ly) + ±
M2 t -/-
M3 / -
M4 t -/-
MA P IDC v/v
MI (Ly) +/-
M2 t +/-
M3 t +/-
DS P TC +/+
Ml (Ly) +/-
M2 t +/-
M3 t +/_
BR P LC -/-
Ml (Ly) +/-
M2 A +/-
BO P LC -/-
MI (Ly) +/-
M2 t -/-
SA P LC
MI (Ly)
ZA P LC
Ml (Ly) +1-
PE P IDC
MI (Ly) +/-
TE P IDC +/-
MI (Ly) +/-
M2 t +X_
M3 t +/_
CA M (Pu) IDC -/-
DO M (Sc) -/-
DI M (Ce) + +
FA M (Pu) --
ST M (Sc) +/-
DM M (Pu) --
P:primarytumour. M: individualconcomitantmetastasis. Ly:lymphonodal. Pu:pulmonary.
Sc: subcutaneous. Ce: cerebral. IDC: infiltrating ductalcarcinoma. TC: tubularcarcinoma. LC:
lobular carcinoma. +: homogeneous stain. ±: very weak stain. v: stain of heterogeneous
intensity. -: no stain. a Cell stain/stain polarised at the basal aspect of cells placed at the
periphery of tumour cell nests.
cases not shown) were found to be negative for a6 and P4
stain over a wide range of MoAb concentrations. Stain for P1
subunit performed in four of these lesions was however
consistently positive. All the described staining patterns
remained unchanged when using additional MoAb HP2/1
and 3E1 to the a6 and P4 chains respectively.
Relationship between integrinphenotype and basement
membrane antigens in primary breast tumours
In order to assess whether the changes in expression and
cellular compartmentalisation of the a6 and P4 subunits
observed in primary mammary tumours might be associated
with an altered distribution of basement membrane, in aINTEGRIN CHANGES IN BREAST CANCER 321
selected number of tumours staining of a6 and P4 subunits
was compared with the distribution of basement membrane
glycoprotein laminin and of collagen type IV. Because a6
chain can alternately dimerise with the P1 subunit to form a
non promiscuous receptor for laminin, the expression of this
chain was also evaluated in the same specimens. From the
results of this study, which are summarised in Table III, the
following information could be obtained. On the tumour cell
plasma membrane a6 was almost invariably coexpressed with
P4 and P11. Polarisation of the stain at the basal aspect of the
cells located at the periphery of tumour nests was seen for
a6, P4 and P1 and for a6 and P1 only in those tumours which
were also stained by the anti-laminin and collagen type IV
antiserum. i.e. tumours possessing an antigenically integer
basement membrane. Lack of detectable laminin and col-
lagen type IV in five out of seven cases was associated with
negative stain for all of the three integrin subunits.
Discussion
The study of the interaction of cells with extracellular matrix
components is instrumental in understanding cell
differentiation, tissue morphogenesis and the pathogenetic
pathways of tumour growth and metastatic spreading. These
areas of study are being increasingly explored since the
identification of the superfamily of the integrin molecules
which mediate a number of specific ligand-receptor interac-
tions between cells and their surrounding milieu (Hynes,
1987; Albelda & Buck, 1990). Different molecular
mechanisms may perturb integrin functions during tumour
progression, including qualitative and quantitative changes in
integrin expression (Hirst et al., 1986; Plantefaber & Hynes,
1989) as well as loss of integrin ligands, i.e. extracellular
matrix components (Ruoslahti & Giancotti, 1989; Giancotti
& Ruoslahti, 1990). Indeed recent immunohistochemical
studies have extended to human tumours the earlier observa-
tions obtained either in tissue culture systems or in animal
Table III Expression of a6 and P4 integrin subunits, laminin and
collagen type IV in primary breast tumours
Patient Histotype az6 P4 P1 laminin coil. IOb
Fac IDC /a / ±/- / -
Stra -/- - -- -I- -
Del +/- _/- +/- -/-
Dic +/+ v/- -/- -/- is
Mas +/- ±/- +/- -/- -
Scia +/± +/- v/is -/- v
Baf ± ±/+ +/+ +/± v
Pet v/± +1- v/± -/is v
Ter _/- v/- v/- -/- nt
Fio -/- -/- v/- +/- -
Fid t -- -- -- -
Acc +/+ ±/+ +I+ +1+ +
Rub +/+ +/± +/+ -I- +
Fun -/+ -/- -/- -1 -
San LC v /v -/- v /+ v/v v
Bra ;k -- I- -I- -I/- Luc ;:%~v/+ v/+ v/+ /+ +
Cic TC ±/+ ±/- v/+ ±/+ -
Val A +/v v/is v/- -/-
Dri v /- ±/- ±/- -/ -
Sci not el- +l- -I no s
Nt: not tested.- no stain. v: heterogeneous stain. _:very weak
stain.is: stain in isolated areas. +:homogeneous stain. IDC:infiltrating ductalcarcinoma. LC: lobularcarcinoma. TC: tubularcarcinoma. aCell membranestain/stainpolarised at the basal aspect ofcellsplaced at the peripheryoftumourcell nests. bStainingatthebaseoftumourcell nests.
models (McGregor et al., 1989; Albelda et al., 1990; Wolf et
al., 1990; Natali et al., 1991). In agreement with others
(Koukoulis et al.,1991; Streuli et al., 1991) we have shown
that a6 and 134 integrin subunits are expressed by normal
mammary epithelium. This pattern is retained in benign
breast tumours whereas it undergoes quantitative and
qualitative changes upon malignant transformation. To gain
further insights into the possible role of these integrins in
tumour progression, we have extended the immunohis-
tochemical analysis to metastatic lesions. This included the
evaluation of the two subunits both in primary tumours and
multiple concomitant autologous metastases, as well as in
metastases sampled from different anatomical sites. Because
ultrastructural and immunohistochemical studies have dem-
onstrated the frequent loss of basement membrane in breast
carcinomas (Ozzello, 1979; Natali et al., 1984; Birombaut et
al., 1985; Tsubura et al., 1988) we have additionally studied
whether changes in integrin profile are paralleled by
modification of the basement membrane-associated glycop-
rotein, laminin, and of collagen type IV.
In mammary tumours of most common histotypes we have
observed a number ofmodifications in a6 and P4 distribution
pattern. Because of the lack of myoepithelial differentiation
in the majority of breast tumours (Gould et al., 1980), stain-
ing of a6 and P4 pertaining to these non parenchymal cells
was rarely seen. The two subunits were mostly undetectable
on tumour cells or redistributed over their plasma membrane.
These changes, which in our specimens are not related to a
given tumour histotype, are almost invariably associated with
lack of laminin and collagen type IV at the periphery of the
tumour cell nests. Thus the availability of specific ligand/s in
the basement membrane appears to direct a polarised expres- sion of the a6/134 heterodimer in normal epithelium, whereas
in breast tumour cells the lack of physical interaction
between the a6/P4 dimer and the basement membrane may be responsible for some of the above described changes. In view of the finding that laminin may function as a stop signal to cell migration (Coopman et al., 1991), the
transformation-associated changes both in integrin repertoire
and basement membrane components may be relevant in
determining the invasive behaviour of breast tumour cells.
In contrast to the results reported by Falcioni et al. (1986) and Wolf et al. (1990), the present findings and those of
Gould et al. (1991) indicate that tumour progression in
breast cancer is not associated with increased levels ofexpres- sion of a6/134.
Our comparative study of primary tumours and auto-
logous metastases has shown a high degree of heterogeneity
in expression of the two subunits. This includes differences
between the primary neoplasia and autologous metastases
(67% of the cases) and to a minor extent among the latter
lesions. Thus the modulation of the a6/134 complex does not
appear to be related to the metastatic process in breast
carcinoma. Nevertheless differences in integrin phenotype between lymph node and parenchymal metastases suggest
that expression of the x6/P4 complex may be modulated by local factors such as cytokines (Heino et al., 1989) in addi-
tion to extracellular matrix components.
In conclusion our data show that loss of basement memb-
rane components parallels quantitative and qualitative
changes in the expression of x6/134 and a6/P1I heterodimers in
breast cancer. This may be a crucial step in enhancing local
invasiveness of tumour cells, thus facilitating tumour
spreading and biological malignancy.
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